Liver cancer diagnostic marker, kit and application of liver cancer diagnostic marker
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
- Publication Date
- 2020-08-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the technical field of biomedical diagnosis, in particular to the application of a liver cancer diagnostic marker, a kit and the liver cancer diagnostic marker. Background technique
[0002] Hepatocellular carcinoma (HCC) is one of the common malignant tumors in my country. Because of its insidious onset, early diagnosis is difficult, it often progresses to the middle and late stage at the time of treatment, and it is often accompanied by intrahepatic metastasis, and the treatment effect is poor. The reason is the lack of effective early diagnosis methods, so the early diagnosis of HCC has always been a research hotspot. At present, alpha fetoprotein (AFP) has been used for early diagnosis of HCC, but its sensitivity and specificity are not high. Studies have confirmed that the accuracy of using AFP alone to diagnose HCC is only 60%, especially for early HCC, its diagnostic sensitivity is greatly reduced; at the same time, patients...